Compare EU & BME Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | EU | BME |
|---|---|---|
| Founded | 2009 | 2005 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Other Metals and Minerals | Trusts Except Educational Religious and Charitable |
| Sector | Basic Materials | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 503.7M | 536.7M |
| IPO Year | N/A | N/A |
| Metric | EU | BME |
|---|---|---|
| Price | $2.42 | $40.81 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $4.00 | N/A |
| AVG Volume (30 Days) | ★ 2.2M | 34.0K |
| Earning Date | 11-10-2025 | 01-01-0001 |
| Dividend Yield | N/A | ★ 6.26% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 1.44 |
| Revenue | ★ $44,142,000.00 | N/A |
| Revenue This Year | $22.24 | N/A |
| Revenue Next Year | $86.15 | N/A |
| P/E Ratio | ★ N/A | $28.37 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.01 | $35.53 |
| 52 Week High | $4.19 | $43.20 |
| Indicator | EU | BME |
|---|---|---|
| Relative Strength Index (RSI) | 39.38 | 61.36 |
| Support Level | $2.66 | $39.81 |
| Resistance Level | $2.87 | $40.67 |
| Average True Range (ATR) | 0.18 | 0.42 |
| MACD | -0.01 | -0.12 |
| Stochastic Oscillator | 14.09 | 57.59 |
enCore Energy Corp together with its subsidiary, is engaged in the acquisition and exploration of resource properties of uranium resource properties in the United States. The holds a portfolio of uranium assets located in New Mexico, South Dakota, Wyoming, Texas, Utah, Colorado, and Arizona in the USA, and is advancing its properties with a focus on utilizing in-situ recovery. The company's Projects are South Texas Operations, Dewey-Burdock Project, Gas Hills Project, Crownpoint & Hosta Butte Project, PFN (Prompt Fission Neutron) Technology, and Other Assets.
Blackrock Health Sciences Trust has an investment objective to provide total return through a combination of current income, current gains, and long-term capital appreciation. The Fund invests 80% of its total assets in equity securities of companies engaged in the health sciences and related industries and equity derivatives.